Entity family

Browse treatments

Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.

7,227articles mentioning treatments

16,644treatment mentions

4,719distinct treatments extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted treatments

Showing 4,081–4,140 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.

passive pharmacovigilance1 patching1 patellar taping1 pathogenic weight loss methods1 pathologically targeted disease-modifying therapies1 pecto-intercostal fascial plane block1 pediatric liver transplantation1 pegvisomant therapy1 pelvic floor exercises1 pelvic floor muscle training1 pelvic floor physiotherapy1 pelvic floor reconstruction1 pentobarbital burst suppression1 peptide receptor radionuclide therapy1 peptide-based vaccines1 percutaneous Kirschner wire fixation1 percutaneous auricular neuromodulation1 percutaneous cervical vagus nerve block1 percutaneous coronary balloon angioplasty1 percutaneous coronary interventions1 percutaneous cryoneurolysis1 percutaneous electrolysis1 percutaneous interventions1 percutaneous transhepatic approach1 percutaneous transhepatic glue embolisation1 percutaneous vertebral augmentation1 peri-articular corticosteroid injection1 peri-articular local infiltration analgesia1 periacetabular osteotomy1 periarticular injections1 pericapsular nerve group block1 pericardial pulmonary vein patch repair1 pericardiectomy1 perinatal resuscitation1 periodontal therapy1 periodontal treatment1 perioperative antibiotic prophylaxis1 perioperative optimisation management1 perioperative pain treatments1 perioperative portal vein embolisation1 permanent MMA embolization1 personalised gene therapy treatments1 personalised management strategies1 personalised stents1 personalised therapy1 personalised treatment1 personalized cancer vaccines1 personalized diabetes management1 personalized treatment1 pesticides1 pharmaceutical asthma therapies1 pharmaceutical treatment1 pharmaceutical treatments1 pharmacist-led medication reviews1 pharmacologic agents1 pharmacologic options1 pharmacologic therapies1 pharmacologic thromboprophylaxis1 pharmacologic treatments1 pharmacologic vasoconstriction1

View all 4,719 treatments on one page

Articles mentioning treatments

7,227 articles · page 160 of 603

IDDF2026-ABS-0043 Post-ablation evolution of liver function and recurrence in treatment-naïve HCC: a seven-state multi-state model integrating ALBI grade and recurrence

gutjnl · abstract · 2026-06-26 · 2 matching annotations

79.9%

ablation HCC hepatocellular carcinoma

…luded 266 treatment-naïve, first-line HCC patients treated with ablation (mean follow-up 14.2 months, range 1–66). Liver function was ca…

IDDF2026-ABS-0051 Influencing factors and a predictive model for acute gastrointestinal injury in critically ill copd patients undergoing mechanical ventilation

gutjnl · abstract · 2026-06-26 · 2 matching annotations

93.2%

mechanical ventilation COPD chronic obstructive pulmonary disease

…s with chronic obstructive pulmonary disease (COPD) who undergo mechanical ventilation, and to develop a predictive model.Methods A total of 908 criti…

IDDF2026-ABS-0094 Clinical outcomes and safety of GPC3-directed CAR-T therapy in advanced hepatocellular carcinoma: a systematic review of early-phase trials

gutjnl · abstract · 2026-06-26 · 2 matching annotations

79.9%

Chimeric antigen receptor T-cell (CAR-T) therapy GPC3-directed CAR-T therapy Hepatocellular carcinoma HCC PubMed GPC3 Glypican-3 Google Scholar

…and its surface localization enables immune-mediated targeting. Chimeric antigen receptor T-cell (CAR-T) therapy directed against GPC3 has shown early antitumor activity in pha…

IDDF2026-ABS-0141 Identification of a novel lacticaseibacillus casei strain CY01 from radiotherapy responders for mitigating acute radiation-induced intestinal injury

gutjnl · abstract · 2026-06-26 · 2 matching annotations

88.4%

radiotherapy CY01 ARII Acute radiation-induced intestinal injury (ARII)L. casei CY01 Lacticaseibacillus casei CY01

…ion-induced intestinal injury (ARII) is a common side effect of radiotherapy. While probiotics offer potential relief, conventional strains …

IDDF2026-ABS-0155 A metabolo-radiomics multimodal intelligent model for predicting radiotherapy sensitivity in rectal cancer

gutjnl · abstract · 2026-06-26 · 2 matching annotations

88.3%

radiotherapy rectal cancer RC colorectal cancer

…l holds significant clinical potential for guiding personalized radiotherapy strategies.Abstract IDDF2026-ABS-0155 Figure 1Abstract IDDF2026…

IDDF2026-ABS-0158 Ecological modulation of streptococcus anginosus by bacillus coagulans: implications for gastric injury and carcinogenesis

gutjnl · abstract · 2026-06-26 · 2 matching annotations

78.9%

BC treatment gastric carcinogenesis SA-induced gastric injury SA-associated gastric injury

…oss, and metaplastic alterations ( IDDF2026-ABS-0158 Figure 1). BC treatment significantly alleviated SA-induced gastric damage. Western blo…

IDDF2026-ABS-0210 Repeated washed microbiota transplantation sustains long-term clinical benefits in radiation enteritis: a prospective cohort study

gutjnl · abstract · 2026-06-26 · 2 matching annotations

76.5%

Repeated WMT Washed microbiota transplantation Second Affiliated Hospital of Nanjing Medical University abdominal or pelvic malignancies Radiation enteritis (RE)

…d, all resolving spontaneously without intervention.Conclusions Repeated WMT is a safe and effective long-term management strategy for RE. C…

IDDF2026-ABS-0221 Nomogram for predicting metachronous recurrence after endoscopic submucosal dissection of superficial esophageal squamous cell carcinoma and precancerous lesions

gutjnl · abstract · 2026-06-26 · 2 matching annotations

84.0%

ESD superficial esophageal squamous cell carcinoma Second Hospital of Hebei Medical University Tianjin Medical University General Hospital Metachronous recurrence precancerous lesions

…ods We conducted a retrospective study on patients who received ESD for superficial esophageal squamous cell carcinoma or precancer…

IDDF2026-ABS-0236 Neurotensin promotes peri-necrotic HCC survival via redox homeostasis and immunosuppressive niche remodeling

gutjnl · abstract · 2026-06-26 · 2 matching annotations

85.8%

anti-PD-1 therapy Hepatocellular carcinoma (HCC)Neurotensin (NTS)

…CC model in immunocompetent mice, either alone or combined with anti-PD-1 therapy.Results Peri-necrotic tumor regions were characterized by hypox…

IDDF2026-ABS-0370 Development and validation of a nomogram for predicting moderate-to-severe acute gastrointestinal injury in patients with sepsis: a retrospective cohort study

gutjnl · abstract · 2026-06-26 · 2 matching annotations

93.5%

mechanical ventilation

…tors were independently associated with moderate-to-severe AGI: mechanical ventilation, multiple organ dysfunction syndrome (MODS), higher admission S…

IDDF2026-ABS-0382 Circulating proteins responsive to energy-restricted diets are associated with hepatic steatosis improvement in MASLD

gutjnl · abstract · 2026-06-26 · 2 matching annotations

88.1%

Energy-restricted diets metabolic dysfunction-associated steatotic liver disease (MASLD)MASLD type 2 diabetes

…Background Energy-restricted diets are a cornerstone treatment for metabolic dysfunction-associate…

IDDF2026-ABS-0412 Application of a tissue biomarker to risk-stratify barrett’s esophagus in rural texas

gutjnl · abstract · 2026-06-26 · 2 matching annotations

78.1%

radiofrequency ablation eradication therapy esophageal adenocarcinoma Castle Biosciences Barrett’s esophagus NDBE BE

… intermediate risk and 2 as high risk; all 7 patients underwent radiofrequency ablation, resulting in complete eradiation of BE. The remaining 99 patie…